Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
AV8 Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
AV8 Ventures

AV8 Ventures

Operating

AV8 Ventures: A Palo Alto-based venture capital firm, investing in visionary startups in health, mobility, and enterprise tech.

Location
Palo Alto, CA, US
Founded
2018
Firm
Compare
Portfolio
Employees
Website

Investments

Cerby
Cerby

Total Raised

$32.5M

Rounds

4

Series A$17MAugust 2023
Pre-Seed$3.5MSeptember 2020
One Model
One Model

Total Raised

$44.8M

Rounds

4

Series Unknown$41MAugust 2023
Embrace
Embrace
Series B

Total Raised

$77.2M

Rounds

6

Series B$20MJuly 2023
Series B$45MOctober 2021
Hydrolix
Hydrolix

Total Raised

$30M

Rounds

3

Series A$20MJune 2023
Seed$10MFebruary 2021
Axuall
Axuall

Total Raised

$40.4M

Rounds

4

Series B$20MMay 2023
Series A$10.4MJuly 2021
Clever Care Health Plan
Clever Care Health Plan

Total Raised

$139M

Rounds

5

Series C$42MMarch 2023
Series B$71MSeptember 2021
Shennon Biotechnologies
Shennon Biotechnologies

Total Raised

$13M

Rounds

1

Seed$13MMarch 2023
CuraFi
CuraFi

Total Raised

$6.8M

Rounds

2

Seed$5MFebruary 2023
Glow
Glow

Total Raised

$28.5M

Rounds

3

Series A$24MNovember 2022
Eclypsium
Eclypsium

Total Raised

$49M

Rounds

5

Series B$25MOctober 2022
Series B$13MOctober 2020
Think Bioscience
Think Bioscience

Total Raised

$17.3M

Rounds

2

Seed$17MAugust 2022
Delfi Diagnostics
Delfi Diagnostics

Total Raised

$330.5M

Rounds

3

Series B$225MJuly 2022
Series A$100MJanuary 2021
Covertree
Covertree

Total Raised

$10M

Rounds

2

Seed$8MMay 2022
SimBioSys
SimBioSys

Total Raised

$15M

Rounds

1

Series A$15MOctober 2021
Alpha Medical
Alpha Medical

Total Raised

$35M

Rounds

2

Series B$24MSeptember 2021
Measured Analytics and Insurance
Measured Analytics and Insurance

Total Raised

$9.3M

Rounds

3

Series UnknownSeptember 2021
Locomation
Locomation

Total Raised

$57M

Rounds

5

Seed$34MJuly 2021
Brave Care
Brave Care
Series B

Total Raised

$41.6M

Rounds

4

Series A$10MApril 2021